Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
CRISPR and iPSCs: recent developments and future perspectives in neurodegenerative disease modelling, research, and therapeutics
Neurodegenerative diseases are prominent causes of pain, suffering, and death worldwide.
Traditional approaches modelling neurodegenerative diseases are deficient, and therefore …
Traditional approaches modelling neurodegenerative diseases are deficient, and therefore …
CRISPR-Cas9 genome engineering: treating inherited retinal degeneration
Gene correction is a valuable strategy for treating inherited retinal degenerative diseases, a
major cause of irreversible blindness worldwide. Single gene defects cause the majority of …
major cause of irreversible blindness worldwide. Single gene defects cause the majority of …
Human in vitro models of epilepsy using embryonic and induced pluripotent stem cells
MS Javaid, T Tan, N Dvir, A Anderson, T J. O'Brien… - Cells, 2022 - mdpi.com
The challenges in making animal models of complex human epilepsy phenotypes with
varied aetiology highlights the need to develop alternative disease models that can address …
varied aetiology highlights the need to develop alternative disease models that can address …
[HTML][HTML] Correction of NR2E3 associated enhanced S-cone syndrome patient-specific iPSCs using CRISPR-Cas9
Enhanced S-cone syndrome (ESCS) is caused by recessive mutations in the photoreceptor
cell transcription factor NR2E3. Loss of NR2E3 is characterized by repression of rod …
cell transcription factor NR2E3. Loss of NR2E3 is characterized by repression of rod …
CLN3, at the crossroads of endocytic trafficking
SL Cotman, S Lefrancois - Neuroscience letters, 2021 - Elsevier
The CLN3 gene was identified over two decades ago, but the primary function of the CLN3
protein remains unknown. Recessive inheritance of loss of function mutations in CLN3 are …
protein remains unknown. Recessive inheritance of loss of function mutations in CLN3 are …
Application of induced pluripotent stem cells in epilepsy
S Hirose, Y Tanaka, M Shibata, Y Kimura… - Molecular and Cellular …, 2020 - Elsevier
Epilepsy is among the most common neurological disorders, affecting approximately 50
million people worldwide. Importantly, epilepsy is genetically and etiologically …
million people worldwide. Importantly, epilepsy is genetically and etiologically …
[HTML][HTML] Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): More than a mere co-morbidity
K Rietdorf, EE Coode, A Schulz, E Wibbeler… - … et Biophysica Acta (BBA …, 2020 - Elsevier
The neuronal ceroid lipofuscinoses (NCLs) are mostly seen as diseases affecting the central
nervous system, but there is accumulating evidence that they have co-morbidities outside …
nervous system, but there is accumulating evidence that they have co-morbidities outside …
[HTML][HTML] Robust genome and RNA editing via CRISPR nucleases in PiggyBac systems
CRISPR/Cas-mediated genome editing in human pluripotent stem cells (hPSCs) offers
unprecedented opportunities for develo** in vitro disease modeling, drug screening and …
unprecedented opportunities for develo** in vitro disease modeling, drug screening and …
Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report
AM Fortress, KJ Miyagishima, AA Reed… - Stem cell research & …, 2023 - Springer
Abstract National Eye Institute recently issued a new Strategic Plan outlining priority
research areas for the next 5 years. Starting cell source for deriving stem cell lines is as an …
research areas for the next 5 years. Starting cell source for deriving stem cell lines is as an …
Patient-derived induced pluripotent stem cell models for phenotypic screening in the neuronal ceroid lipofuscinoses
Batten disease or neuronal ceroid lipofuscinosis (NCL) is a group of rare, fatal, inherited
neurodegenerative lysosomal storage disorders. Numerous genes (CLN1–CLN8, CLN10 …
neurodegenerative lysosomal storage disorders. Numerous genes (CLN1–CLN8, CLN10 …